Extension Study of ABP-671 in Participants With Gout
Clinical trial NCT06276556 · TERMINATED
Trial details
- NCT number
- NCT06276556
- Sponsor
- Atom Therapeutics Co., Ltd
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-22
- Primary completion
- 2024-09-05
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.